Anteris Technologies Ltd (ASX:AVR) insider Stephen (Steve) Denaro bought 5,000 shares of the stock in a transaction on Monday, June 7th. The stock was acquired at an average cost of A$8.01 ($5.72) per share, for a total transaction of A$40,045.00 ($28,603.57).
Anteris Technologies Company Profile
Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies.
Featured Article: Holder of Record
Receive News & Ratings for Anteris Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies and related companies with MarketBeat.com's FREE daily email newsletter.